DE3874030D1 - 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel. - Google Patents

1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel.

Info

Publication number
DE3874030D1
DE3874030D1 DE8888401588T DE3874030T DE3874030D1 DE 3874030 D1 DE3874030 D1 DE 3874030D1 DE 8888401588 T DE8888401588 T DE 8888401588T DE 3874030 T DE3874030 T DE 3874030T DE 3874030 D1 DE3874030 D1 DE 3874030D1
Authority
DE
Germany
Prior art keywords
benzensulfonyl
alkylthio
oxo
production
intermediate products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888401588T
Other languages
English (en)
Other versions
DE3874030T2 (de
Inventor
Emilio Toja
Carlo Zirotti
Fernando Barzaghi
Giulio Galliani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE3874030D1 publication Critical patent/DE3874030D1/de
Application granted granted Critical
Publication of DE3874030T2 publication Critical patent/DE3874030T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8888401588T 1987-06-29 1988-06-23 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel. Expired - Fee Related DE3874030T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8721098A IT1215590B (it) 1987-06-29 1987-06-29 Derivati della 1-benzene solfonil 2-oco 5-alchiltio pirrolidina, un loro procedimentodi preparazione e il loro impiegocome stostanze medicinali.

Publications (2)

Publication Number Publication Date
DE3874030D1 true DE3874030D1 (de) 1992-10-01
DE3874030T2 DE3874030T2 (de) 1993-03-25

Family

ID=11176711

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888401588T Expired - Fee Related DE3874030T2 (de) 1987-06-29 1988-06-23 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel.

Country Status (9)

Country Link
US (1) US4897414A (de)
EP (1) EP0298818B1 (de)
JP (1) JPS6426557A (de)
DE (1) DE3874030T2 (de)
ES (1) ES2051876T3 (de)
GR (1) GR3005521T3 (de)
IT (1) IT1215590B (de)
MX (1) MX174141B (de)
PT (1) PT87852B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1228462B (it) * 1989-02-23 1991-06-19 Roussel Maestretti S P A Milan Derivati del 1 arilsolfonil pirrolidin 2 tione oppure del 1 arilsolfonil piperidin 2 tione, loro procedimento di preparazione e loro impiego come medicinali.
BR9712792A (pt) * 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117975A (en) * 1960-04-22 1964-01-14 Rohm & Haas Substituted pyrrolidinones and piperidinones
US3423426A (en) * 1966-01-25 1969-01-21 Chevron Res N-(polyhaloalkylthio) alkenylsuccinimides
US3686169A (en) * 1970-07-20 1972-08-22 Monsanto Co Thiocycloamides
FR2553409B1 (fr) * 1983-10-18 1986-04-18 Choay Sa Nouveaux benzenesulfonyl-lactames, leur procede de preparation et leur application comme substance active de compositions pharmaceutiques
CH666891A5 (de) * 1985-11-26 1988-08-31 Lonza Ag 4-alkoxy-2-oxo-pyrrolidin-1-yl-essigsaeure-c(1)-c(4)-alkylester, deren herstellung und verwendung.
DK167393B1 (da) * 1985-12-30 1993-10-25 Roussel Uclaf 1-sulfonyl-2-oxo-pyrrolidinderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf

Also Published As

Publication number Publication date
MX12051A (es) 1993-10-01
EP0298818A1 (de) 1989-01-11
IT8721098A0 (it) 1987-06-29
ES2051876T3 (es) 1994-07-01
IT1215590B (it) 1990-02-14
PT87852A (pt) 1988-07-01
EP0298818B1 (de) 1992-08-26
JPS6426557A (en) 1989-01-27
MX174141B (es) 1994-04-25
DE3874030T2 (de) 1993-03-25
US4897414A (en) 1990-01-30
PT87852B (pt) 1992-10-30
GR3005521T3 (de) 1993-06-07

Similar Documents

Publication Publication Date Title
ATA312987A (de) Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE58904567D1 (de) Quinuclidine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung.
DE68904104T2 (de) Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE3582995D1 (de) 9-amino-1,2,3,4-tetrahydroacridin-1-ol und verwandte verbindungen, verfahren zu ihrer herstellung und verwendung als arzneimittel.
DE3869205D1 (de) 2-phenylpurinon-derivate, verfahren zu ihrer herstellung, ihre verwendung sowie zwischenprodukte.
ATE184602T1 (de) Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
DE3860503D1 (de) 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung.
DE3867364D1 (de) Stabilisiertes kaugummiprodukt und verfahren zu dessen herstellung.
DE3882319T2 (de) Lederartiges Schichtprodukt und Verfahren zu dessen Herstellung.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3581725D1 (de) Aminoacyllabdane, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung als arzneimittel.
DE3767977D1 (de) Lacton-abbauprodukt, verfahren zu dessen herstellung und dessen verwendung.
DE3687515T2 (de) Oxa-, thia- und diazabicycloalkanderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
DE68903425D1 (de) Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
DE3886936T2 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
DE3484023D1 (de) Azolylmethylcycloalkane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE69716284T2 (de) Erythromycin-derivate, verfahren zur herstellung und verwendung als arzneimittel
DE3874030D1 (de) 1-benzensulfonyl-2-oxo 5-alkylthio pyrrolidin-derivate, verfahren zur herstellung und zwischenprodukte und verwendung als heilmittel.
DE68903629T2 (de) Pulverfoermiges imidazolin-produkt und verfahren zu dessen herstellung.
DE3485988T2 (de) Cinnamoylverbindungen, verfahren zur herstellung und ihre verwendung als heilmittel.
DE3585388D1 (de) Verfahren zur herstellung von 1,3 cyclohexandionderivaten und zwischenprodukte dazu.
DE58902864D1 (de) Plastisol-formmassen, verfahren zu ihrer herstellung und ihre verwendung.
DE3866485D1 (de) Verpackungsmaterial, verfahren zur herstellung und verwendung.
ATE62488T1 (de) A-aminoaryldihydropyridinlactone, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee